Lennox-Gastaut Syndrome: An Update on Treatment

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

• Publication date

  2012-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S0317167100015535PMID 23227575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SCN1A-Related Seizure Disorders

  2014cited by this paper
• [Treatment of pediatric epilepsy].

  2014cited by this paper
• New concepts in classification of the epilepsies: Entering the 21st century

  2011cited by this paper
• Rational approach to treatment options for Lennox‐Gastaut syndrome

  2011cited by this paper
• A 6-month prospective study on efficacy safety and QOL profiles of extended-release formulation of valproate in patients with epilepsy.

  2011cited by this paper
• Effectiveness of vagal nerve stimulation (VNS) in patients with drop-attacks and different epileptic syndromes.

  2011cited by this paper
• Definition and natural history of Lennox‐Gastaut syndrome

  2011cited by this paper
• Neuropsychological development in children with Dravet syndrome.

  2011cited by this paper
• Rufinamide: A New Antiepileptic Medication for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome

  2010cited by this paper
• Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009

  2010cited by this paper
• Lennox-Gastaut syndrome (LGS): development of conceptual models of health-related quality of life (HRQL) for caregivers and children.

  2010cited by this paper
• Lennox-Gastaut syndrome in adulthood: clinical and EEG features.

  2010cited by this paper
• Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.

  2010cited by this paper
• First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy.

  2010cited by this paper
• Experience with rufinamide in a pediatric population: a single center's experience.

  2010cited by this paper
• Adjunctive rufinamide in Lennox‐Gastaut syndrome: a long‐term, open‐label extension study

  2010cited by this paper
• Medical management of Lennox-Gastaut syndrome

  2010cited by this paper
• Clobazam in the treatment of Lennox‐Gastaut syndrome

  2009cited by this paper
• Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology.

  2009cited by this paper
• Factors influencing the evolution of West syndrome to Lennox-Gastaut syndrome

  2009cited by this paper
• Impact of Lennox-Gastaut Syndrome (LGS) on health-related quality of life (HRQL) of patients and caregivers: literature review.

  2009cited by this paper
• SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features.

  2009cited by this paper
• Vagus nerve stimulation in pediatric epileptic syndromes.

  2009cited by this paper
• Long-term vagus nerve stimulation in the treatment of Lennox-Gastaut syndrome.

  2009cited by this paper
• Factors influencing the evolution of West syndrome to Lennox-Gastaut syndrome.

  2009cited by this paper
• Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome.

  2008cited by this paper
• Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome

  2008cited by this paper
• Treatment of Lennox-Gastaut syndrome: overview and recent findings

  2008cited by this paper
• The spectrum of SCN1A-related infantile epileptic encephalopathies.

  2007cited by this paper
• Treatment of pediatric epilepsy: European expert opinion, 2007.

  2007cited by this paper
• An Emerald Event

  2005cited by this paper
• Seizure-related injuries in a group of young people with epilepsy wearing protective helmets: incidence, types and circumstances.

  2005cited by this paper
• Treatment of Pediatric Epilepsy: Expert Opinion, 2005

  2005cited by this paper
• Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

  2005cited by this paper
• Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

  2005cited by this paper
• The lennox-gastaut syndrome: A severe type of childhood epilepsy

  2004cited by this paper
• Levetiracetam in the treatment of Lennox-Gastaut syndrome.

  2004cited by this paper
• Worsening of Seizures by Oxcarbazepine in Juvenile Idiopathic Generalized Epilepsies

  2004cited by this paper
• Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

  2004cited by this paper
• Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

  2004cited by this paper
• Lennox-Gastaut Syndrome (Childhood Epileptic Encephalopathy)

  2003cited by this paper
• Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V).

  2001cited by this paper
• Vagus Nerve Stimulation in Children with Refractory Seizures Associated with Lennox–Gastaut Syndrome

  2001cited by this paper
• Long‐Term Seizure Outcome in 74 Patients with Lennox–Gastaut Syndrome: Effects of Incorporating MRI Head Imaging in Defining the Cryptogenic Subgroup

  2000cited by this paper
• Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?

  2000cited by this paper
• A Risk-Benefit Assessment of Therapies for Lennox-Gastaut Syndrome

  2000cited by this paper
• Myoclonus Associated with the Use of Gabapentin

  2000cited by this paper
• A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group.

  1999cited by this paper
• A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome

  1999cited by this paper
• Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet.

  1999cited by this paper
• Occurrence, Outcome, and Prognostic Factors of Infantile Spasms and Lennox‐Gastaut Syndrome

  1999cited by this paper
• Rash in Adult and Pediatric Patients Treated with Lamotrigine

  1998cited by this paper
• Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.

  1997cited by this paper
• Prevalence and Descriptive Epidemiology of Lennox‐Gastaut Syndrome Among Atlanta Children

  1997cited by this paper
• For generalized seizures associated with the Lennox-Gastaut syndrome

  1997cited by this paper
• Tiagabine and non-convulsive status epilepticus.

  1996cited by this paper
• Evolution of Lennox‐Gastaut Syndrome: A Long‐Term Longitudinal Study

  1996cited by this paper
• Incidence of Epilepsy in Childhood and Adolescence: A Population‐Based Study in Nova Scotia from 1977 to 1985

  1996cited by this paper
• Efficacy of felbamate in therapy for partial epilepsy in children.

  1994cited by this paper
• The Lennox‐Gastaut Syndrome

  1993cited by this paper
• Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

  1993cited by this paper
• The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin.

  1993cited by this paper
• Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

  1989cited by this paper
• Sodium Valproate: Monotherapy and Polytherapy

  1982cited by this paper
• The Lennox-Gastaut syndrome: a personal study.

  1982cited by this paper
• Treatment of Generalized Epilepsies of Childhood and Adolescence with Sodium Valproate (‘Epilim’)

  1977cited by this paper
• Tonic Status Epilepticus precipitated by Intravenous Benzodiazepine in Five Patients with Lennox‐Gastaut Syndrome

  1972cited by this paper
• Childhood Epileptic Encephalopathy with Slow Spike‐Wave A Statistical Study of 80 Cases

  1972cited by this paper

• What Is Epilepsy?

  2020cites this paper
• Aspek genetik dan manifestasi klinis varian young onset Parkinson disease

  2020cites this paper
• Lennox gastaut syndrome- A case report and review of treatment protocol

  2020cites this paper
• What Is Epilepsy

  2018cites this paper
• Long-term Outcome of Resective Epilepsy Surgery in Patients With Lennox-Gastaut Syndrome

  2018cites this paper
• Early Diagnosis and Treatment of Lennox-Gastaut Syndrome

  2017influential citation
• Epileptic Encephalopathy in Infants and Children

  2016cites this paper
• Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study.

  2016cites this paper
• Development and validation of a stability indicating liquid chromatographic method for the analysis of rufinamide bulk material and dosage forms

  2016cites this paper
• Rufinamide in patients with Lennox-Gastaut syndrome

  2016cites this paper
• Dietary therapy is not the best option for refractory nonsurgical epilepsy

  2015cites this paper
• Lennox-Gastaut syndrome

  2015cites this paper
• Levetiracetam: Pharmacological properties, safety and efficacy in the pediatric population with epilepsy

  2014cites this paper
• Epileptic Encephalopathies: New Genes and New Pathways

  2014cites this paper